Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury

Circulation Research

Volumn 78, Issue 1, 1996, Pages 38-43

  Bendeck, Michelle P ^a,b   Irvin, Colleen ^a   Reidy, Michael A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

artery; injury; matrix metalloproteinases; neointima; rat

Indexed keywords

COLLAGENASE; ILOMASTAT;

ANIMAL CELL; ANIMAL MODEL; ARTERY INJURY; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTICLE; BASEMENT MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; DRUG EFFECT; ENZYME INHIBITION; GROWTH REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0030064282     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.1.38     Document Type: Article

References (26)

1. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
2. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990;67:61-67.
3. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 1993; 13:1218-1226.
4. Jackson CL, Reidy MA. The role of plasminogen activation in smooth muscle cell migration after arterial injury. Ann N Y Acad Sci. 1992;667:141-150.
5. Jackson CL, Reidy MA. Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. Am J Pathol. 1993;143: 1024-1031.
6. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays. 1992;14:455-463.
7. Bendeck MP, Zempo N, Clowes A, Galardy R, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994;75:539-545.
8. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
9. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
10. Sasaguri Y, Murahashi N, Sugama K, Kato S, Hiraoka K, Satoh T, Isomoto H, Morimatsu M. Development-related changes in matrix metalloproteinase expression in human aortic smooth muscle cells. Lab Invest. 1994;71:261-269.
11. Grobelny D, Poncz L, Galardy RE. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry. 1992;31: 7152-7154.
12. Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries: interaction of heparin with basic fibroblast growth factor. J Clin Invest. 1992;90: 2044-2049.
13. Jenkins GM, Crow M, Bilato C, Li Z, Ryu W, Froehlich J, Lakatta E, Cheng L. The role of MMP-2 in neointimal formation following balloon injury in the rat. FASEB J. 1994;8:A51. Abstract.
14. Mignatti P, Tsuboi R, Robbins E, Rifkin DB. In vitro angiogenesis on the human arnniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol. 1989;108:671-682.
15. Pepper MS, Belin D, Montesano R, Orci L, Vassalli J-D. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol. 1990;111:743-755.
16. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumour invasion. Physiol Rev. 1993;73:161-195.
17. Fisher SJ, Cui TY, Zhang L, Hartman L, Grahl K, Zhang GY, Tarpey J, Damsky CH. Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol. 1989;109: 891-902.
18. Southgate KM, Davies M, Booth RFG, Newby AC. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J. 1992;288:93-99.
19. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG, Crow MT. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res. 1994;75:41-54.
20. Adams JC, Watt FM. Regulation of development and differentiation by the extracellular matrix. Development. 1993;117: 1183-1198.
21. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619-626.
22. Reidy MA, Jackson J, Lindner V. Neointimal proliferation: control of vascular smooth muscle growth. Vasc Med Rev. 1992;3:156-167.
23. Reidy MA, Fingerle J, Lindner V. Factors controlling the development of arterial lesions after injury. Circulation. 1992;86(suppl): 43-46.
24. Reidy MA. Neointimal proliferation: the role of basic FGF on vascular smooth muscle cell proliferation. Thromb Haemost. 1993; 70:172-176.
25. Reidy MA. Growth factors and arterial smooth muscle cell proliferation. Ann NY Acad Sci. 1994;714:225-230.
26. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.